These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 614601)

  • 1. [The "e" antigen (HBeAg) in leprosy].
    Nuti M; Tarabini GC; Tarabini GC; Thamer G
    Quad Sclavo Diagn; 1977 Dec; 13(4):393-403. PubMed ID: 614601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy and hepatitis B virus markers: incidence of HBsAg and HBeAg in Somalian patients.
    Nuti M; Tarabini G; Palermo P; Tarabini GL; Thamer G
    Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):580-4. PubMed ID: 122628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytotoxins in leprosy and in asymptomatic hepatitis B virus infection.
    Serjeantson S; Dry P
    Clin Exp Immunol; 1980 Feb; 39(2):289-96. PubMed ID: 7389201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hepatitis A and B virus markers (anti-HAV, HBsAg, HBsAb, HBeAg, HBeAb) in leprous patients (author's transl)].
    Ferlazzo B; Barrile A; Puglisi A; Tigano F
    Ann Sclavo; 1980; 22(3):355-62. PubMed ID: 6264868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological pattern of hepatitis B virus markers (HBsAg, anti-HBs, IgM anti-HBc and HBV specific DNA polymerase) in leprosy patients.
    Moudgil KD; Irshad M; Gandhi BM; Mishra R
    Indian J Lepr; 1989 Jan; 61(1):54-60. PubMed ID: 2649622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leprosy and hepatitis B].
    Chiron JP; Denis F; Yvonnet B; Coursaget P; Diop Mar I; Languillon J
    Acta Leprol; 1985; 3(2):169-99. PubMed ID: 3907255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B surface antigen (HBsAg) in leprosy patients of Calcutta: its prevalence and subtypes.
    Chakrabarty MS; Mukherjee KK; Chakrabarty SK; Ghosh S; Choudhury S
    Lepr India; 1979 Apr; 51(2):182-8. PubMed ID: 480908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B antigen in a leprosy hospital.
    Kelkar SS; Niphadkar KB; Khare PM; Junnarkar RV
    Bull World Health Organ; 1973 May; 48(5):555-8. PubMed ID: 4204489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis-B-surface antigen (HBsAg) in leprosy patients.
    Balakrishnan S; Bhatia VN; Harikrishnan S
    Lepr India; 1983 Jan; 55(1):45-8. PubMed ID: 6876759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hepatitis B virus markers, in leprous patients (author's transl)].
    Chiron JP; Denis F; Maupas P; Goudeau A; Coursaget P; Languillon J; Roux G
    Nouv Presse Med; 1979 Feb; 8(9):659-62. PubMed ID: 450680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis-B virus infection in patients with leprosy--a brief communication.
    Katoch VM; Katoch K; Dutta AK; Sharma VD; Ramu G
    Lepr India; 1983 Apr; 55(2):193-6. PubMed ID: 6632778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.
    Lau GK; Lok AS; Liang RH; Lai CL; Chiu EK; Lau YL; Lam SK
    Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.